Thymus-derived (T) lymphocytes mediate several immune functions, including cytotoxicity against specific target cells in vitro (1) . T cells with different functions have distinct surface markers of the Ly series (1) (2) (3) (4) (5) (6) . The surface phenotype of the T cell set that destroys allogeneic target cells is Lylh:Ly23+ (Ly23 cells) (3) (4) (5) (6) . However, the phenotype of T cells capable of destroying synguneic tumor targets, presumably by reacting against tumor-associated transplantation antigens, has been reported as Lyl+:Ly23+ (Ly123 cells) (7) .
One factor that must be considered in comparing cell-mediated cytotoxicity (CMC) for allogeneic and tumor-associated systems is the difference in the length of time involved in the respective assays. The allogeneic assays are short-term (3-4 hr) and display single-hit kinetics, and the frequency of reactive cells is relatively high (8) . In most syngeneic systems, long-term assays (20 hr or more) are required, the kinetics of which have not been defined (9, 10) . Our present analysis of long-term assays for syngeneic tumor cytotoxicity shows that they involve participation by at least two sets of T cells. The Lyl+:Ly23-(Lyl) population, which is not itself cytotoxic, augments the generation of Ly23 cytotoxic T cells. Thus, although CMC against syngeneic mammary tumor cells is mediated by Ly23 cells at all stages of the assay, as we shall show, Lyl cells, and probably Ly123 cells, are needed to implement a maximal Ly23-mediated effector response.
MATERIALS AND METHODS
Animals and Tumors. The C3Hf and C3H mice used are derived from the colony of the late Dr. J. J. Bittner at the University of Minnesota (Umc sublines), and have been bred by one of us (O.S.) since 1973 (10) . Mice used for the production of Ly antisera are described in ref. 11 . All the present studies were done with MT. 1, a spontaneous C3H/Umc mammary adenocarcinoma described in ref. 10 . The PO.4 tumor referred to in Table 3 is a polyoma-induced mammary tumor of C3Hf origin, which is not crossreactive with MT. 1 (also described in ref. 10 ).
Immunizations. Two-to four-month old C3Hf females were immunized by injection of 5 X 105 viable tumor cells in one or both hind footpads, followed by excision of the growing tumor 15-20 days later. Cells from the regional inguinal and popliteal lymph nodes were obtained from these animals 7-9 days after excision, which is the optimal timing for the maximal T-dependent cytotoxic response (10) .
Target Cells. An established cell line derived from MT.1 (10) was used in all the in vitro assays. The MT. 1 cells were passed serially in vitro in T-60 plastic flasks (Falcon Plastics, Los Angeles, CA) with culture medium made of RPMI 1640 (Grand Island Biological, Grand Island, NY) supplemented with 15% fetal bovine serum and insulin at 10 ,g/ml.
Cell-Mediated Cytotoxicity Assay. The procedure is similar to that described in refs. 9 and 10. Monolayer cultures of target cells in T-60 flasks were incubated for 20-24 hr with 250 ,ACi of [3H]proline (L-[2,3-3H(N)]proline, with specific activity of 40-50 Ci/mmol, from New England Nuclear Corp., Boston, MA) in 5 ml of complete Hanks' minimal essential medium (without nonessential amino acids, i.e., without proline) with 15% fetal bovine serum. The cultures were then washed three times at 370 with complete minimal essential medium containing 15% fetal bovine serum and 2% nonessential amino acids. The cells were detached with 0.05% Tryptar (Armour Pharmaceutical, Chicago, IL) in Puck's saline A (0.02% EDTA used on occasions) and the cell concentrations were adjusted so that 10 ,l would contain 1000 cells. Ten microliters of cell suspension was distributed with a microliter syringe (Hamilton Co., Whittier, CA) into the wells of Falcon microtest plates II (no. 3040, Falcon Plastics, Los Angeles, CA) prefilled with 0.1 ml of culture medium. Effector cells were added 6 hr later in 0.1 ml of culture medium at 100:1 lymphocyte/target ratios. The plates were then incubated at 370 in humidified 5% CO2 in air for 30 hr, unless otherwise indicated. At the end of the Abbreviations: a, anti-; C, complement; CMC, cell-mediated cytotoxicity; E:T ratio, effector-to-target-cell ratio; Lyl, Lyl+:Ly23-; Ly23, LylV:Ly23+; Ly123, Lyl+:Ly23+; T, thymus-dependent (lymphocytes).
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The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. incubation period, the plates were inverted and slightly shaken to remove medium and effector cells. The plates were then submerged three times in phosphate-buffered saline with 5% fetal bovine serum at 370 (a large volume being used and changed after every wash), emptied, and left to dry. When dry, the plates were sprayed lightly with Fluoro-glide (Chemplast, Inc., Wayne, NJ) and the bottoms of the wells were punched out by the use of a hand-operated cam punch press (Rope Whitney, Rockford, IL) with a cutting die 6.528 mm in diameter and a punch 6.350 mm in diameter. The punched bottoms were transferred to scintillation vials and 0.3 ml of Hyamine hydroxide (Packard Instrument Co., Downers Grove, IL) was added to each flask. After 30 min, 10 ml of toluene with scintillation fluid (Packard Permablend I, Packard Instrument Co.) was added. The vials were kept at 40 for at least 24 hr before measuring radioactivity (to ensure complete solubilization of target cell protein). All the tests were performed in three to five replicates. The results are expressed as mean cpm + SEM or as percent cytotoxicity calculated according to the formula 100(1 -A/B), in which A = target cell cpm remaining after incubation with immune effector cells, and B = target cell cpm remaining after incubation with nonimmune effector cells. Serological Reagents and Procedures. The Ly reagents used, and relevant serological procedures, are described in ref. 11 [for description of the anti-Thy-1.2 (aThy-1.2) serum see also refs. 9 and 10]. These standard procedures were used in the experiments described in Tables 1 and 2 and also to select the Lyl or Ly23 populations referred to in Tables 3 and 4 . In Fig.  2 , the procedure was different, because the complement (C)-dependent cytotoxicity technique was performed directly on the microwells where CMC was taking place. In selected wells of the Falcon II microtest plates, at different times (0-24 hr) after initiation of the 30-hr CMC assay, most of the culture fluid was removed with a pasteur pipette and replaced with 0.025 ml of C and 0.025 ml of aLy sera at a predetermined dilution. The trays were then placed for 45 min at 370 for the C-dependent cytotoxicity to be completed, after which the wells were filled with 0.35 ml of culture media, and incubation was continued to complete the standard total of 30 hr. The 0.35 ml of culture medium produces an additional 20-fold dilution of antiserum + C during the remainder of the assay period. reagents (i.e., only with culture media), and (ii) with C alone. The Ly antisera were titrated by their addition to the CMC assay, at dilutions of 1:20 to 1:1000, at intervals of 6, 18, and 24 hr after initiation, and measuring CMC at 30 hr, as well as by the conventional cytotoxicity assay based on exclusion of trypan blue (11) . The useful endpoint titer for our pool of aLy-1.1 was 1:1000, and 1:200 for the aLy-2.1; these were the dilutions selected for use in experiments.
RESULTS
Effect of Pretreatment of Cytotoxic T Cells with aLy-1 and aLy-2 Antisera. Table 1 shows an example of the results obtained when immune lymph node cells are pretreated in vitro with aLy-1, aLy-2, or aThy-1 antisera and C (which lysed 50-55, 20-25, and 60-70% of the cells, respectively) on CMC against syngeneic C3H mammary adenocarcinoma cells in vitro (after 30 hr incubation at 100:1 effector-to-target, E:T, ratio). As shown in previous work (10), the response is mediated by T cells as indicated by the marked effect of the aThy-1 treatment. CMC was equally affected by pretreatment of the effector T cells with aLy-1 or aLy-2 (63 and 82% reduction of CMC, respectively). These results seem to support the report by Shiku et al. (7) that the effector cells in syngeneic tumor systems are Ly123.
Time Course of the CMC Response. Before trying to determine the Ly phenotype of the effector T cells in our system, it seemed imperative to determine the kinetics of the response. Fig. 1 shows the percent CMC when measured at 2-hr intervals from 0 time to 36 hr of incubation (at 100:1 E:T ratios). The response is biphasic, with an early peak at 6 hr, which levels off for approximately 12 hr and is followed by a second peak that reaches its maximum after 24-30 hr of incubation, with no further increment. This biphasic curve was observed in every instance in seven different experiments, of which Fig. 1 is a representative example.
The Late CMC Peak Is Mediated by Ly23 T Cells. Fig. 2 shows the effects of selective T cell elimination at different times during the assay (0, 6, 12, 18, and 24 hr), the response then being allowed to continue for the usual total of 30 hr. The most notable effect was that although both aLy-1 and aLy-2 sera lowered the response when applied during the early phase, most of the effector cells active during the 18-to 24-hr periodwere insensitive to aLy-1 serum, and therefore presumably were of the Ly23 phenotype. Three additional experiments gave similar Proc. Natl. Acad. Sci results. To test further the specificity of the reduction produced by aLy-2 serum during the later phase, two portions of aLy-2.1 serum were absorbed respectively with: (i) T cells from C57BL/6/Ly-2.1 mice, and (ii) T cells from C57BL/6/Ly-2.2 mice. The former absorbed antiserum failed to abolish CMC activity, whereas the latter absorbed antiserum abolished CMC activity, as before. Thus, the CMC reduction produced by aLy-2.1 serum in the late phase is due specifically to the elimination of Ly23 cells.
The Early CMC Peak Is Also Mediated by Ly23 T Cells. Because the early events of the response are not adequately defined by treating with aLy serum at different time points and allowing the test to continue for its full 30-hr duration (see Fig.  2 ), we tested the effects of selecting with the aLy sera and measuring CMC at 6 and 12 hr after incubation instead of 30 hr. Table 2 shows that the early peak of CMC, observed at 6 and 12 hr, was also exclusively mediated by Ly23 cells; elimination with aLy-1 leaves the small early CMC peak intact while aLy-2 abolished it. Thus, both the early peak (Table 2) , and the late CMC peak (Fig. 2) , are mediated by Ly23 cells.
Although Ly3 phenotypes were not ascertained in the experiments described above, we use the notation LyI23, byl, and Ly23 in relation to the three known T cell Ly phenotypes (1, 4) Table 3 ). Table 3 imply that both Lyl and Ly23 sets are required for optimal CMC. However, the comparisons in such experiments were favoring the mixtures (prepared by mixing the two cell types at 100:1 E:T ratios of each class, i.e., a total of 200:1 E:T ratios). A more detailed study of mixtures at different ratios is presented in Table 4 . When tested individually at ratios ranging from 50:1 to 200:1, it was apparent' that the Lyl cells were not cytotoxic even at the highest ratio, while the Ly23 cells were cytotoxic only, although less so than the unfractionated population. The mixtures of Lyl and Ly23 cells gave a substantial degree of restoration of CMC, higher than the sum of the two cell types alone (especially at the lower E:T ratios; last three lines of Table 4 ), but this did not in any instance reach the level of the unfractionated cells. Table 4 ).
DISCUSSION
This study shows that long-term assays designed to measure CMC against syngeneic tumors in vitro are complex (Fig. 1 (Tables 3 and  4) , indicating a helper or amplifier interaction with Ly23 pre-killer cells. Both sets must come from immunized donors and therefore the Lyl helper may induce "non-lytic secondary T cells" (12) or cause specific cytotoxic memory T cells to become cytotoxic effector Ly23 cells (8, 12) . Our unpublished data also show that cooperation is seen when Lyl helper cells are added to Ly23 cells as late as 18 hr after initiation of the assay, suggesting rapid induction that may not entail proliferation of the Ly23 cells but rather may entail a final differentiative step. The cytotoxic activity of mixtures of different ratios of Lyl and Ly23 cells indicates that even at the lowest ratios (Table 4) there is true synergy, the response being always greater than the additive effects of the two populations used in the mixture. However, the use of large numbers of the Ly23 population (200:1 E:T ratio) may circumvent the need for Lyl help ( (1977) 
